Upsher-Smith Laboratories

Upsher-Smith Laboratories


Company description

Upsher-Smith Laboratories, LLC is a trusted U.S. pharmaceutical company striving to improve the health and lives of patients through an unwavering commitment to high-quality generic and branded products and sustainable growth.

Upsher-Smith Laboratories, LLC is a fully integrated pharmaceutical company focused on commercialization of prescription pharmaceutical products in the U.S. market. With our diverse portfolio of high-quality products, we strive to improve the health and lives of patients. In 2019 we celebrate our centennial anniversary and enter a new ambitious era accelerated by our 2017 acquisition by Osaka, Japan-based Sawai Pharmaceutical Co., Ltd.

Over the past 100 years we have offered a broad array of generics serving a wide span of disease states and conditions. In addition, we’ve built a commercial infrastructure focused on the epilepsy and migraine segments that has resulted in the addition of Qudexy® XR (topiramate extended-release capsules), Vigadrone® (vigabatrin powder for oral solution), Tosymra™ (sumatriptan nasal spray) and Zembrace® SymTouch® (sumatriptan injection) to our branded product portfolio. Our drugs are delivered to a variety of customers, always backed by an attentive level of service, strong industry relationships, and a dedication to uninterrupted supply.

Upsher-Smith is currently seeking partners with a solid history of success and a vision for future growth and innovation, who can help us expand both our brand and generic portfolios. We are specifically interested in opportunities to acquire, license or co-develop:

- Diverse dosage-form generic products, including ophthalmics and injectables
- Differentiated 505b2 products in the epilepsy and migraine categories
- Late-stage assets, both brands and generics

Together, we seek to deliver the best value for our mutual stakeholders, and most importantly, to do more good for the patients we serve. For more information, visit

Quick facts

Affiliated categories: Finished Dosage Forms |Out-licensing |Sprays More

Recently at

5 nov 2019

CPhI Worldwide 2019

5-7 November 2019 Frankfurt, Germany We were at stand 41D50 See our Exhibitor Profile   See full Exhibitor List

Categories affiliated with Upsher-Smith Laboratories

Upsher-Smith Laboratories

Contact information




View all contact information